ClinConnect ClinConnect Logo
Search / Trial NCT06432439

Impact of Microneedling on Coverage of RT1 Gingival Recession in Thin Phenotype.

Launched by POSTGRADUATE INSTITUTE OF DENTAL SCIENCES ROHTAK · May 22, 2024

Trial Information

Current as of May 28, 2025

Not yet recruiting

Keywords

Microneedling Phenotype Gingival Recession Coronally Advanced Flap

ClinConnect Summary

This clinical trial is studying a treatment for a common dental issue known as gingival recession, where the gums pull back from the teeth, exposing the tooth roots. This condition can cause sensitivity, cosmetic concerns, and even tooth decay. The trial aims to see if a procedure called microneedling, which involves using tiny needles to stimulate the gums, can thicken the gum tissue. This could help improve the results of a surgical technique called Coronally Advanced Flap (CAF), which is used to cover the exposed roots more effectively.

To be eligible for this study, participants must be between 20 and 50 years old and have specific types of gum recession (known as isolated RT1 recessions) in the front of their mouths, along with some sensitivity or aesthetic concerns. They must also be in good overall health and committed to maintaining good oral hygiene. Participants can expect to undergo microneedling before the CAF procedure, and they will be closely monitored throughout the study. It’s important to know that individuals with certain health conditions, smokers, or those who have had previous gum surgery in the affected areas will not be eligible for this trial.

Gender

ALL

Eligibility criteria

  • INCLUSION CRITERIA:
  • Presence of isolated (RT1) by Cairo et al 2011 buccal maxillary gingival recessions in esthetic zone including maxillary central incisors, lateral incisors and canines associated with esthetic complaints and/or dental sensitivity and otherwise systemically healthy.
  • Gingival Recession ≥2mm and clinically identifiable CEJ
  • Age 20years-50 years
  • Patient demonstrating compliance for maintaining good oral hygiene after Phase 1 thearpy Plaque index (PI) \<1, Gingival Index (GI) \<1
  • Providing a written and verbal informed consent.
  • EXCLUSION CRITERIA
  • Patient with systemic disease that can influence the outcome of therapy.
  • Pregnant females or on oral contraceptive pills or hormone replacement therapy.
  • Smokers and patients undergoing orthodontic therapy
  • Physically and mentally impaired patients.
  • Non vital, malpositioned tooth
  • Presence of cervical abrasions or restorations in the area
  • Previous history of periodontal surgery on the involved sites.

About Postgraduate Institute Of Dental Sciences Rohtak

The Postgraduate Institute of Dental Sciences, Rohtak, is a premier academic institution dedicated to advancing dental education, research, and clinical practice. With a commitment to fostering innovation in oral health, the institute is actively engaged in conducting clinical trials that aim to enhance treatment methodologies and improve patient outcomes. By integrating cutting-edge research with comprehensive training, the institute plays a pivotal role in shaping the future of dental sciences, while adhering to the highest ethical standards and regulatory guidelines in clinical research.

Locations

Patients applied

0 patients applied

Trial Officials

Amisha Goyal, BDS

Principal Investigator

PGIDS

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported